Insmed, Inc. (INSM) Social Stream



Insmed, Inc. (INSM): $19.72

-0.35 (-1.74%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add INSM to Watchlist
Sign Up

Industry: Biotech


Ranked

of 398

in industry

INSMED Inc (INSM) Price Targets From Analysts

Use the tables below to see what analysts covering INSMED Inc think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-29 9 $60 $43 $52.777 $24.21 118%
2021-12-06 9 $60 $43 $52 $24.21 114.79%
2021-12-21 8 $60 $43 $52.444 $24.21 116.62%
2022-01-31 8 $60 $42 $51.333 $24.21 112.03%
2022-02-18 8 $60 $43 $51.666 $24.21 113.41%
2022-02-22 8 $56 $40 $50 $24.21 106.53%

The Trend in the Analyst Price Target


Over the past 41 weeks, INSM's average price target has gone down $3.01.

Over the past 46 weeks, INSM's average upside potential has been 92.99%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-05-08 2 60 41 53.560 32.58 64.4%
2021-05-15 2 60 41 53.330 26.23 103.32%
2021-06-05 2 60 41 53.330 25.33 110.54%
2021-12-21 8 60 43 52.444 28.35 84.99%
2022-02-22 8 56 40 50.000 22.43 122.92%

INSM Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.06 7 1 0 0 0 8

The Trend in the Broker Recommendations


Over the past 123 days, INSM's average broker recommendation rating improved by 0.32.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In terms of how INSMED Inc fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 801.01% of that group.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, INSMED Inc's variance in analysts' estimates is lower than -163.64% of them.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, INSMED Inc's number of analysts covering the stock is greater than 704.74% of them.
  • INSMED Inc's average analyst price target is greater than 692.31% of Pharmaceutical Products stocks.

Stocks similar to INSMED Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are INFI, IMAB, and IGMS.

Make investment decisions regarding INSM using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4739 seconds.